@Article{Zimmermann-Górska2007,
journal="Przewodnik Lekarza/Guide for GPs",
issn="1505-8409",
year="2007",
title="Agents for the treatment of rheumatic diseases",
abstract="Characteristics of the TNF-\α blocking agents (infliximab, etanercept, adalimumab), IL-1 blocking agent (anakinra), costimulatory blocking agent (abatacept) and anti-CD20 monoclonal antibody (rituximab), their efficacy in the most frequent inflammatory rheumatic diseases, their toxicity as well as the emerging biological therapies, are presented.",
author="Zimmermann-Górska, Irena",
pages="40--47",
url="https://www.termedia.pl/Agents-for-the-treatment-of-rheumatic-diseases,8,8193,1,1.html"
}